Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System

Wuhan University

Status

Unknown

Conditions

Bowel Preparation

Adenoma

Treatments

Other: Observational group

Study type

Observational

Funder types

Other

Identifiers

NCT04591145

EA-20-002

Details and patient eligibility

About

A deep learning based system to calculate the proportion of Boston Bowel Prep Scale (BBPS) score of 0-1 during withdrawal phase has been constructed previously. This multi-center study is going to perform a prospective observational study to validate the threshold of the adequate proportion.

Full description

Inadequate bowel preparation is insufficient for identification of polyps greater than 5 mm. However, bowel preparation assessment involved subjectivity and uncertainty. We constructed a deep learning based system to calculate the proportion of Boston Bowel Prep Scale (BBPS) score of 0-1 during withdrawal phase and performed a prospective observational study to validate the threshold of the adequate proportion.The multi-center study is aimed to verify the extrapolation and robustness of the scoring threshold based on artificial intelligence intestinal cleanliness evaluation system explored in the early stage, and propose a more accurate and quantifiable threshold for evaluating the eligibility of intestinal preparation.

Enrollment

1,400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male or female aged 18 years or above;
Ability to read, understand and sign informed consent forms;
The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.

Exclusion criteria

Patients with contraindications to colonoscopy (obstruction or perforation, severe acute inflammatory bowel disease, toxic megacolon, severe heart failure, severe heart failure, etc.);
Patients with galactosemia;
Pregnant or lactating women;
Patients used lactulose, a stimulant, or laxative within 7 days;
Patients refused to sign informed consent forms.